Treatment for smallpox and related virus infections
Part of Infections clinical trials.
This trial tests a medicine called tecovirimat for people exposed to or infected with viruses like smallpox, monkeypox, or cowpox, and for those with serious vaccine reactions. The medicine may help treat these infections and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be affiliated with the U.S. Department of Defense (DoD), including employees, contractors, dependents, or allied forces
- You must have been exposed to or infected with a pox virus, or have a serious side effect from a smallpox vaccine
- You must be available for follow-up visits during treatment and after
- You must be able to swallow capsules
- You must not be allergic to tecovirimat
- You must not be breastfeeding, or you must be willing to pause breastfeeding during treatment and for at least 30 days after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This is an observational study that follows people with confirmed monkeypox (mpox) to better understand the illness over time. It may help doctors learn what to expect and improve care, but it does not test a new treatment.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
This is an observational study that follows adults after they get a monkeypox vaccine to learn how their immune system responds. The results may help researchers understand what types of protection the vaccine creates.
Hear when a new Smallpox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.